Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism

Executive Summary

Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.

You may also be interested in...



NASS 2020: Medtronic Announces First Patient Implant With InterStim Micro, Adaptix Interbody System Launch

Medtronic’s next-generation InterStim Micro system for overactive bladder is more competitive with Axionics’ r-SNM system, according to an analyst. Medtronic continues to innovate as its former CEO announces retirement.

Medtronic’s Anti-Bacterial Implantable Device Envelope Proves Cost-Effective In Study

A new analysis of the WRAP IT study shows the Tyrx absorbable antibacterial envelope is a cost-effective tool for preventing infections around cardiac implantable electronic devices.

Medtronic Initiates Restructuring Program To Save Up To $475M Annually

The medtech giant will simplify its organizational structure, consolidate operations and give more autonomy to its individual operating units.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142635

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel